With a focus on stem cells, Jeremy Purvis, PhD, wants to tap the power of computer modeling to develop regenerative medicine solutions to medical conditions.
Susan G. Komen announced UNC Lineberger researcher Charles M. Perou, PhD, as the recipient of this year's Brinker Award for Scientific Distinction in Basic Science for his contributions to the understanding of breast cancer as distinct molecular subtypes that have prognostic value using cutting-edge cancer genomics tools.
In the study published in the Journal of Clinical Oncology, UNC Lineberger researchers report that nearly a third of a group of patients with chronic myeloid leukemia, and who have federally-funded Medicare health insurance, did not start treatment within six months of diagnosis with any of three targeted drugs that have led to dramatic improvements in survival for the disease.
In a new British Medical Journal editorial, UNC School of Medicine researchers and physicians stress the need for better worldwide surveillance of e-cigarette-related burns and better regulation of e-cigarettes to reduce burn injuries.
David Weber, MD, MPH, Matt Collins, MD, PhD, and Helen Lazear, PhD, were the featured speakers addressing the Zika virus epidemic during lecture at the UNC School of Medicine.
Park pens column on UNC Hospitals' Environmental Services Gospel Choir for Healthcare Executive Magazine
Gary Park, President of UNC Hospitals, contributed a column entitled Harmonious Healthcare for the September/October 2016 issue of Healthcare Executive Magazine, the official magazine of the American College of Healthcare Executives. The piece features the Environmental Services Gospel Choir, a UNC Hospitals employee-run volunteer choir that performs for patients and employees.
In an analysis of survival data for a population of patients with a particular type of head and neck cancer, UNC Lineberger researchers confirmed that a particular strain of HPV, a virus linked to multiple cancers, resulted in better overall survival for patients with oropharyngeal cancer than patients with other strains of the virus.
iTech project will target people under the age of 30, the population with most new HIV infections in US. The effort is led by Lisa Hightow-Weidman, MD, MPH, associate professor of medicine.
UNC researchers publish special report exploring the reasons why PhD-trained scientists choose careers in or out of academia.
Autism researchers will use new technology to study baby teeth of children who have siblings with autism to learn if siblings are more likely to develop the disorder if exposed to chemicals while in the womb.
UNC School of Medicine’s Michael O’Shea, MD, is the principal investigator for the $5-million grant to analyze data and follow children over time to study the origins of diseases and conditions.
Renovion and EpiCypher, spinouts from the work of David Henke, MD, and Brian Strahl, PhD, respectively, were celebrated this week at the National Council of Entrepreneurial Tech Transfer’s University Startups Demo Day
To address full cardiac arrest of hospital patients, new measures reduced the average time between symptom onset and the start of treatment by 72 percent.
Virologists with the UNC School of Medicine participated in last week's on-campus recording of a popular virology podcast.
On Thursday, Sept. 15, 2016, Sepsis Alliance held its fifth annual Sepsis Heroes: Celebrating Champions of Sepsis Awareness gala in New York City. UNC medical student Hillary Spangler was one of five honorees recognized as a Sepsis Hero. This annual event celebrates and applauds the work of individuals and organizations that have made great strides in raising sepsis awareness.
A UNC Lineberger study published in the journal Breast Cancer Research and Treatment drew upon surveys that assessed health-related quality of life issues for women aged 20 to 74 years who lived in North Carolina and had breast cancer. The analysis was part of the third phase of the Carolina Breast Cancer Study.
Although mutated versions of the protein Cdh1 have not been found in cancers, the protein’s degradation at a key moment during the cell cycle may spur on cancerous cell division.
Ninety-seven percent of trial participants reported hearing improvements in the first year with the use of the SYNCHRONY EAS (Electric Acoustic Stimulation) Hearing Implant System. UNC implanted more patients than any other participating hearing center.
UNC’s residency programs in Anesthesiology, Family Medicine, Emergency Medicine, Internal Medicine, Medicine/Pediatrics, Obstetrics & Gynecology, Otolaryngology, Pediatrics, Psychiatry, Radiation Oncology and Urology are all ranked in the top 30 programs nationwide in the Doximity Residency Navigator.
The new compound could reduce overdoses and possibly curb addiction, while addressing the needs of millions of people suffering with chronic pain.